NEW YORK (Reuters) – Stocks were little changed on Monday as a late rebound in financial stocks offset nagging worries the Chinese government may tighten credit, a move that could slow growth in the global economy.
See more here:
Wall Street ends flat as banks rebound late
WASHINGTON (Reuters) – President Barack Obama faced growing congressional pressure on Monday to get tough with China over its currency practices, one day after Chinese Premier Wen Jiabao brushed off accusations that Beijing was undervaluing its currency for an unfair trade advantage.
Read more from the original source:
U.S. lawmakers press for action on China currency
NEW YORK (Reuters) – Don’t assume that “suggested” retail price on the store shelf is the price that shoppers typically pay.
Read more here:
Carter’s wins lawsuit alleging it inflates prices
CHICAGO (Reuters) – Boston Scientific Corp suspended sales of its implantable heart defibrillators on Monday after failing to notify regulators of changes in how it manufactures the devices, sending shares down as much as 19 percent to a one-year low.
Continued here:
Boston Scientific suspends ICD sales, shares slump
WASHINGTON (Reuters) – The Federal Reserve would gain new powers over non-bank financial firms and keep much of its authority over banks under a new bill on financial regulatory reform unveiled on Monday by the chairman of the Senate Banking Committee, Christopher Dodd.
See the rest here:
Dodd boosts Fed in new financial reforms
NEW YORK (Reuters) – The former president of New York’s privately held Park Avenue Bank was arrested and charged on Monday with being the first person to attempt to steal from U.S. government bailout funds in the financial crisis.
See the original post:
Ex-NY bank president first accused of TARP fraud
NEW YORK (Reuters) – The former president of New York’s privately held Park Avenue Bank was arrested and charged on Monday with being the first person to attempt to steal from U.S. government bailout funds in the financial crisis.
Continued here:
Ex-NY bank president first accused of TARP fraud
WASHINGTON (Reuters) – Senate Banking Committee Chairman Christopher Dodd on Monday unveiled a bill to revamp U.S. financial rules that would place a consumer protection agency within the Federal Reserve and give the central bank new powers over non-bank financial firms.
View original post here:
Dodd unveils bill that puts consumer agency at Fed
BRUSSELS (Reuters) – Euro zone finance ministers discussed the mechanics of a financial rescue for Greece on Monday but gave few details of their standby planning as Athens tries to fix its public finances alone.
BRUSSELS (Reuters) – Euro zone finance ministers discussed the mechanics of a financial rescue for Greece on Monday but gave few details of their standby planning as Athens tries to fix its public finances alone.
Read the rest here:
Euro ministers discuss Greek standby aid planning
WASHINGTON (Reuters) – President Barack Obama faced growing congressional pressure on Monday to get tough with China over its currency practices, one day after Chinese Premier Wen Jiabao brushed off accusations that Beijing was undervaluing its currency for an unfair trade advantage.
Excerpt from:
Lawmakers press for action on yuan
NEW YORK (Reuters) – Stocks fell on Monday as investors worried the Chinese government may tighten credit, potentially slowing the global economy, and waited for a revised financial regulation bill in the Senate.
Here is the original post:
Wall St. lower on China, jitters over bank bill
NEW YORK (Reuters) – Several former American International Group Inc employees might sue the insurer after it gave them less retention bonus money than they should have received, their lawyers said on Monday.
Go here to read the rest:
Ex-AIG employees might sue over lower payouts
NEW YORK (Reuters) – Consol Energy Inc agreed to buy Dominion Resources Inc’s Appalachian natural gas properties for $3.48 billion in cash, giving Consol a leading position in the growing Marcellus Shale field.
Go here to read the rest:
Consol to buy Dominion gas assets for $3.48 billion
CHICAGO (Reuters) – Boston Scientific Corp said it has suspended sales of its implantable heart defibrillators after failing to notify regulators of changes in how it manufactures the devices. It said patient safety was not at risk.
View original here:
Boston Scientific suspends ICD sales; shares slump